CAS 60731-46-6: Elcatonin
Description:Elcatonin is a synthetic peptide that is derived from salmon calcitonin, a hormone involved in calcium regulation and bone metabolism. It is primarily used in the treatment of osteoporosis and other conditions associated with bone loss. Elcatonin functions by inhibiting osteoclast activity, which reduces bone resorption and helps maintain bone density. The substance is typically administered via injection due to its peptide nature, which limits its bioavailability when taken orally. Elcatonin has a relatively short half-life, necessitating frequent dosing to maintain therapeutic levels. Its efficacy in reducing vertebral fractures and improving bone mineral density has been documented in clinical studies. Additionally, Elcatonin may exhibit some analgesic properties, providing pain relief in certain conditions. As with any medication, potential side effects can include nausea, flushing, and allergic reactions, although these are generally mild. Overall, Elcatonin represents a valuable option in the management of osteoporosis and related disorders, contributing to improved bone health and quality of life for patients.
Formula:C148H244N42O47
InChI:InChI=1/C148H244N42O47/c1-69(2)52-92(178-142(231)115(75(13)14)185-128(217)87-30-21-20-22-36-113(208)237-67-84(151)122(211)172-98(59-107(154)200)136(225)176-96(56-73(9)10)134(223)182-102(66-192)139(228)188-116(77(16)193)143(232)171-87)123(212)161-63-109(202)165-85(31-23-25-47-149)124(213)173-95(55-72(7)8)133(222)181-101(65-191)138(227)169-89(41-44-105(152)198)126(215)167-91(43-46-111(204)205)127(216)175-94(54-71(5)6)132(221)177-97(58-82-61-158-68-163-82)135(224)166-86(32-24-26-48-150)125(214)174-93(53-70(3)4)131(220)168-90(42-45-106(153)199)130(219)187-118(79(18)195)145(234)180-100(57-81-37-39-83(197)40-38-81)146(235)190-51-29-35-104(190)140(229)170-88(33-27-49-159-148(156)157)129(218)186-117(78(17)194)144(233)179-99(60-112(206)207)137(226)184-114(74(11)12)141(230)162-62-108(201)164-76(15)121(210)160-64-110(203)183-119(80(19)196)147(236)189-50-28-34-103(189)120(155)209/h37-40,61,68-80,84-104,114-119,191-197H,20-36,41-60,62-67,149-151H2,1-19H3,(H2,152,198)(H2,153,199)(H2,154,200)(H2,155,209)(H,158,163)(H,160,210)(H,161,212)(H,162,230)(H,164,201)(H,165,202)(H,166,224)(H,167,215)(H,168,220)(H,169,227)(H,170,229)(H,171,232)(H,172,211)(H,173,213)(H,174,214)(H,175,216)(H,176,225)(H,177,221)(H,178,231)(H,179,233)(H,180,234)(H,181,222)(H,182,223)(H,183,203)(H,184,226)(H,185,217)(H,186,218)(H,187,219)(H,188,228)(H,204,205)(H,206,207)(H4,156,157,159)/t76-,77+,78+,79+,80+,84-,85-,86-,87?,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,114-,115-,116?,117-,118-,119-/m0/s1
- Synonyms:
- Elcatonin [INN:JAN]
- (Aminosuberic acid 1,7)-eel calcitonin
- Carbocalcitonin
- Elcatonina
- Elcatonina [INN-Spanish]
- Elcatonine
- Elcatonine [INN-French]
- Elcatoninum
- Elcatoninum [INN-Latin]
- Hc-58
- See more synonyms
- 1,7-Dicarbacalcitonin (salmon), 1-butanoic acid-26-L-aspartic acid-27-L-valine-29-L-alanine-
- 1,7-Dicarbacalcitonin, 1-butanoic acid-26-L-aspartic acid-27-L-valine-29-L-alanine-
- 1-Butyric acid-7-(L-2-aminobutyric acid)-26-L-aspartic acid-27-L-valine-29-L-alaninecalcitonin (salmon)
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | (Des-Cys¹,cyclo(Ser²-Asu⁷))-Calcitonin (eel) REF: 01-4025810CAS: 60731-46-6 | 99.9% | 254.00 €~973.00 € | Fri 11 Apr 25 |
![]() | Elcatonin Acetate REF: 7W-GX0702CAS: 60731-46-6 | - - - | To inquire | Wed 16 Apr 25 |
![]() | Elcatonin RS REF: 2K-1029000021CAS: | - - - | To inquire | Wed 23 Apr 25 |
![]() | Elcatonin REF: 3D-FE36658CAS: 60731-46-6 | Min. 95% | - - - | Discontinued product |

(Des-Cys¹,cyclo(Ser²-Asu⁷))-Calcitonin (eel)
Ref: 01-4025810
1mg | 254.00 € | ||
5mg | 973.00 € |

Ref: 2K-1029000021
2x9.1u | To inquire |

Elcatonin
Ref: 3D-FE36658
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |